← SynDRA
SC-9
SynDRA canonical compound SYN0087394 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PRKCA |
|---|
| Mechanism of action | Protein tyrosine kinase activator |
|---|
All known targets
Mechanisms of action (all sources)
- Protein tyrosine kinase activator
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- APOBEC3F
- IDH1
- TDP1
- SMAD3
- POLH
- PLK1
- NFE2L2
- KDM4A
- HKDC1
- APOBEC3G
- GMNN
- GLS
- GLP1R
- CGA
- CBX1
- ATXN2
- WRN
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- IDHC
- IL1B
- PRMT1
- SMCA2
- STK33
- TR10B
Cross-references
Synonyms
- N-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide
- 6-Phcns
- RefChem:162273
- DTXCID5067928
- 5-chloro-N-(6-phenylhexyl)naphthalene-1-sulfonamide
- 5-CHLORO-N-(6-PHENYLHEXYL)-1-NAPHTHALENESULFONAMIDE
- NCM 119
- NCM-119;NCM119;SC 9
- 1-Naphthalenesulfonamide, 5-chloro-N-(6-phenylhexyl)-
- C22H24ClNO2S
- NCGC00024588-01
- Tocris-0433
- SCHEMBL317956
- orb1704080
- SCHEMBL29508099
- CHEBI:92454
- GLXC-04366
- HMS3266O15
- HMS3411K17
- HMS3675K17
- EX-A15178
- MFCD00065544
- AKOS022179640
- FP26980
- MS-32555
- HY-100934
- CS-0020605
- T23334
- SR-01000597646
- SR-01000597646-1
- BRD-K25875056-001-01-2
- BRD-K25875056-001-02-0
- N-(6-phenylhexyl)-5-chloro-1-naphthalene-sulphonamide
- 5-chloro-N-(6-phenylhexyl)-1-naphthalenesulfonamide
Look up SC-9 in the interactive SynDRA portal →